Operating in a heavily regulated industry, Australian health insurers typically produce stable and defensive earnings and, in our opinion, Medibank is well placed to produce solid long-term earnings growth. Future changes to regulations could hurt Medibank’s prospects, but we don’t believe the government would materially damage the viability of the private health insurance sector in Australia. Growth is supported by government reliance on private health insurers to partially fund escalating healthcare costs. Government policies and incentives encourage participation, with 53% of the population covered for private hospital and/or ancillary health insurance.
Key Investment Considerations
- Smaller players on thin margins may need to reign in customer acquisition spend if industry wide claim inflation is not slowed. Medibank can continue to generate attractive returns.
- Mid-single digit earnings and dividend growth, with Medibank’s ability to pay out 75% to 85% of earnings as dividends sustainable.
- Medibank is Australia’s largest private health insurer, with 1.8 million policyholders covering approximately 3.5 million people under the Medibank and ahm brands. Medibank Private was established in 1976 to bring increased competition to the private health insurance industry, with the government selling the business in 2014 via an initial public offering. The ahm business was acquired in 2009, with Medibank successfully using the brand to grow its share of younger customers. The dual brand strategy has successfully allowed the group to offer differentiated pricing and messaging to grow members and profits. Medibank has over 400,000 policyholders under the ahm brand, up from only 160,000 in 2010. In our opinion, Medibank offers steady long-term defensive earnings growth.
- There are 37 registered health insurers in Australia, with the top five accounting for around 80% of the market by policy numbers. Despite the “free” universal public system in Australia, close to 44% of Australia’s population of 25.5 million have private hospital cover due to taxation benefits and penalties, shorter wait times, and a choice of doctor and hospital. We expect government policy settings, which promote the take up and retention of private health insurance products, to remain in place. Long-term growth prospects are supported by government reliance on private health insurers to partially fund escalating healthcare costs. With an ageing population, higher demand for more intense healthcare will further pressure the public health system.
(Source: Morningstar)
Disclaimer
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

